Rs11203203 is associated with type 1 diabetes risk in population pre-screened for high-risk HLA-DR,DQ genotypes

Pediatric Diabetes

Volumn 13, Issue 8, 2012, Pages 611-615

  Johnson, Kelly ^a   Wong, Randall ^a   Barriga, Katherine J ^a   Klingensmith, Georgeanna ^a   Ziegler, Anette G ^b   Rewers, Marian J ^a   Steck, Andrea K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Islet autoimmunity; Type 1 diabetes; UBASH3A

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQB1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN SH3;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK PATIENT; HUMAN; INDEPENDENT VARIABLE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ BETA-CHAINS; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; INFANT; ISLETS OF LANGERHANS; YOUNG ADULT;

EID: 84870063293     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00888.x     Document Type: Article

References (22)

1. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996: 59: 1134-1148.
2. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009: 41: 703-707.
3. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007: 39: 857-864.
4. Reddy MP, Wang H, Liu S et al. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun 2011: 12: 208-212.
5. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007: 447: 661-678.
6. Steck AK, Zhang W, Bugawan TL et al. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR, DQ genotypes? Diabetes 2009: 58: 1028-1033.
7. Cooper JD, Walker NM, Smyth DJ, Downes K, Healy BC, Todd JA. Follow-up of 1715 SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type I diabetes families. Genes Immun 2009: 10: S85-S94.
8. Grant SF, Qu HQ, Bradfield JP et al. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 2009: 58: 290-295.
9. Concannon P, Onengut-Gumuscu S, Todd JA et al. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 2008: 57: 2858-2861.
10. Zhernakova A, Stahl EA, Trynka G et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011: 7: e1002004.
11. Wattenhofer M, Shibuya K, Kudoh J et al. Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains. Hum Genet 2001: 108: 140-147.
12. Rewers M, Bugawan TL, Norris JM et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996: 39: 807-812.
13. Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler AG. IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 2004: 27: 2695-2700.
14. Yu L, Rewers M, Gianani R et al. Anti-islet autoantibodies develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996: 81: 4264-4267.
15. Emery LM, Babu S, Bugawan TL et al. Newborn HLA-DR, DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes 2005: 6: 136-144.
16. Carpino N, Turner S, Mekala D et al. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 2004: 20: 37-46.
17. Bottini N, Musumeci L, Alonso A et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004: 36: 337-338.
18. Vang T, Congia M, Macis MD et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005: 37: 1317-1319.
19. Smyth D, Cooper JD, Collins JE et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004: 53: 3020-3023.
20. Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004: 75: 330-337.
21. Kyogoku C, Langefeld CD, Ortmann WA et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004: 75: 504-507.
22. Barker JM, Barriga K, Yu L et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004: 89: 3896-3902.